This Article contains a typographical error in the Results section under subheading ‘Identification of F12016 as a novel selective PPARγ agonist distinct from rosiglitazone’.
“The chemical name of F12016 is 2-[2-(1, 2-dimethyl-1H-indol-3-yl)-2-oxo-acetylamino]-benzamide, which has not been reported to show any activity.”
should read:
“The chemical name of F12016 is N-(2-acetylpheyl)-2-(1,2-dimethyl-1H-indol-3-yl)-2-oxoacetamide, which has not been reported to show any activity.”
Additional information
The online version of the original article can be found at 10.1038/srep09530
Rights and permissions
About this article
Cite this article
Liu, C., Feng, T., Zhu, N. et al. Correction: Corrigendum: Identification of a novel selective agonist of PPARγ with no promotion of adipogenesis and less inhibition of osteoblastogenesis. Sci Rep 5, 12185 (2015). https://doi.org/10.1038/srep12185
Published:
DOI: https://doi.org/10.1038/srep12185
- Springer Nature Limited